首页> 外文期刊>Genetic Engineering & Biotechnology News: The Information Source of the Biotechnology Industry >Q&A on Sartorius Stedim Biotech/SAFC Deal: Looking at the Rationale for the Agreement and What the Two Companies Plan to Offer
【24h】

Q&A on Sartorius Stedim Biotech/SAFC Deal: Looking at the Rationale for the Agreement and What the Two Companies Plan to Offer

机译:关于Sartorius Stedim生物技术/ SAFC交易的问答:查看协议的原理以及两家公司计划提供的内容

获取原文
获取原文并翻译 | 示例
           

摘要

AFC Biosciences (www.sigma aldrich.com/safc) and Sartorius Stedim Biotech (www.sartorius-stedim.com) recently signed a global partnership agreement that combines Sartorius Stedim Biotech's expertise in filtration and liquid-handling systems with SAFCBiosciences' proficiency in development and manufacturing of cell culture media and downstream purification products. The companies will combine their expertise in generating application data on filter and mixing performance with critical purification buffers and cell culture media. Similarly, extractable and leachable data will be generated with buffers and media, and with filters and biobag combinations.
机译:AFC Biosciences(www.sigma aldrich.com/safc)和Sartorius Stedim Biotech(www.sartorius-stedim.com)最近签署了一项全球合作协议,将Sartorius Stedim Biotech在过滤​​和液体处理系统方面的专业知识与SAFCBiosciences的开发能力相结合以及细胞培养基和下游纯化产品的生产。两家公司将结合他们的专业知识,来生成有关过滤器的应用数据以及关键的纯化缓冲液和细胞培养基的混合性能。同样,将使用缓冲液和介质以及过滤器和生物袋组合生成可提取和可浸出的数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号